NewcelX Ltd. (NCEL)
NASDAQ: NCEL · Real-Time Price · USD
2.650
-0.030 (-1.12%)
At close: Nov 18, 2026, 4:00 PM EST
2.700
+0.050 (1.89%)
Pre-market: Nov 19, 2026, 4:02 AM EST
NewcelX Employees
As of December 31, 2025, NewcelX had 12 total employees, including 9 full-time and 3 part-time employees. The number of employees decreased by 3 or 20.00% compared to the previous year. That makes NewcelX the 39,795th largest employer in the world and 5,885th in the United States.
Employees
12
Change (1Y)
-3
Growth (1Y)
-20.00%
Revenue / Employee
n/a
Profits / Employee
-$222,500
Market Cap
15.31M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 12 | -3 | -20.00% | 9 | 3 |
| Dec 31, 2024 | 15 | 3 | 25.00% | 11 | 4 |
| Dec 31, 2023 | 12 | -19 | -61.29% | 12 | 0 |
| Dec 31, 2022 | 31 | -1 | -3.13% | 31 | 0 |
| Dec 31, 2020 | 32 | - | - | 28 | 4 |
Related Stocks
| Company Name | Employees |
|---|---|
| Seres Therapeutics | 66 |
| Acumen Pharmaceuticals | 61 |
| Citius Pharmaceuticals | 23 |
| Quantum BioPharma | 17 |
| Context Therapeutics | 15 |
| Actuate Therapeutics | 12 |
| Quoin Pharmaceuticals | 6 |
| Pasithea Therapeutics | 5 |
NCEL News
- 9 days ago - NewcelX Announces Pricing of $1.55 Million Equity Financing at 20% Premium Pricing to Market - GlobeNewsWire
- 14 days ago - NewcelX to divest legacy Mazindol portfolio for up to $55M in milestones - TheFly
- 14 days ago - NewcelX Enters into Binding Term Sheet to Divest Legacy Mazindol Portfolio (CVR), Providing for Upfront Cash, Equity Ownership and Up to $55 Million in Potential Milestone Payments - GlobeNewsWire
- 7 weeks ago - NewCelX Management to Attend Breakthrough T1D Congress in Philadelphia, Advancing Its Mission to Develop a Cure for Type 1 Diabetes - GlobeNewsWire
- 3 months ago - NewcelX registers to sell 694K common shares for holders - TheFly
- 3 months ago - NewcelX announces pricing of $1.4M equity financing - TheFly
- 3 months ago - NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing - GlobeNewsWire
- 4 months ago - NewcelX announces Brazil patent for cell selection, enrichment technology - TheFly